Joint Formulary & PAD

Melatonin - Alzheimers disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
NFD1
NICE
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Melatonin
Indication :
Alzheimers disease
Group Name :
Keywords :
insomnia in dementia, sleep disorders in dementia, insomnia in alzheimers disease, alzheimers dementia, Alzheimer's disease, Lewy Body dementia, Vascular dementia,
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Drugs

Below are listed other drugs that are used to treat Alzheimers disease.

Committee Recommendations (1)

 The Surrey Heartlands Integrated Care System Area Prescribing Committee has a agreed a NON-FORMULARY traffic light status for melatonin to manage insomnia in people living with Alzheimer’s disease, in line with NICE guidance (NG97)